Researchers who have used RainDance Technologies Inc.’s ThunderBolts cancer panel said at this week’s American Association for Cancer Research meeting that the next-generation DNA sequencing platform has helped them detect and research mutations in colorectal cancer, esophageal adenocarninoma, pancreatic cancer and breast cancer tumors for as little as $100 per sample.
RainDance announced the official launch of the research-use only sequencing panel at the AACR meeting in San Diego April 5-9....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?